Review:
Orphan Drug Approval Process
overall review score: 4.5
⭐⭐⭐⭐⭐
score is between 0 and 5
The orphan drug approval process refers to the regulatory pathway that allows for the development and approval of drugs intended to treat rare diseases.
Key Features
- Specific criteria for defining a rare disease
- Incentives for drug developers, such as tax credits and market exclusivity
- Orphan drug designation by regulatory authorities
Pros
- Provides opportunities for the development of treatments for rare diseases
- Incentivizes pharmaceutical companies to focus on developing drugs for small patient populations
- Offers financial benefits to encourage investment in orphan drug research
Cons
- Challenges in clinical trial recruitment due to small patient populations
- Limited market potential for orphan drugs may impact pricing and access
- Complex regulatory requirements for orphan drug designation and approval